H.E. Dr. Majid bin Ibrahim Alfayyadh, Chief Govt Officer of King Faisal Specialist Hospital and Analysis Centre (KFSHRC), delivered a keynote deal with on the First Incapacity Analysis Discussion board, organized by the King Salman Heart for Incapacity Analysis in collaboration with King Saud College. The occasion introduced collectively main native and worldwide researchers and specialists in rehabilitation, neuroscience, and genetics. Throughout his deal with, Dr. Alfayyadh highlighted KFSHRC’s pioneering position in analysis and medical innovation geared toward empowering folks with disabilities and enhancing their high quality of life by utilized science and superior therapies.
He famous that incapacity represents one of the vital urgent challenges in medical care, emphasizing that Saudi Arabia information higher-than-average charges of sure uncommon genetic issues. This, he defined, makes analysis on this area each a nationwide precedence and a human duty. Dr. Alfayyadh emphasised that King Faisal Specialist Hospital and Analysis Centre performs a number one position in advancing the fields of genomic medication and clever neurotechnologies, creating sustainable options that allow people to steer extra unbiased and productive lives.
He underscored that genomic medication is a cornerstone of progress in addressing the causes of genetic disabilities. KFSHRC researchers have contributed to the invention of almost 10% of all disease-causing genes recognized worldwide. The hospital has additionally doubled its genomic testing quantity—from 22,000 assessments in 2022 to greater than 44,000 in 2024—and stays the one facility in Saudi Arabia providing whole-genome sequencing for diagnosing uncommon and complicated situations.
Dr. Alfayyadh additionally added that the hospital is conducting superior analysis within the fields of rehabilitation, neurostimulation, and regenerative medication. He additional highlighted KFSHRC’s analysis in creating implantable neural chips to revive mobility and communication in sufferers with spinal wire accidents, epilepsy, and Alzheimer’s illness. These breakthroughs are being pushed by the Translational Neuroengineering Heart, which unites physicians and engineers to speed up the interpretation of scientific discovery into real-world medical purposes.
Within the area of autism and neurodevelopmental issues, Dr. Alfayyadh defined that KFSHRC is among the many first facilities globally to combine multi-omics applied sciences into prognosis and therapy, rising diagnostic accuracy to 40% and paving the best way for the event of recent biomarkers for focused therapies.
Dr. Alfayyadh additionally joined a high-level panel dialogue alongside worldwide specialists to discover rising analysis traits, collaboration alternatives, and revolutionary approaches to bettering rehabilitation companies and high quality of life for folks with disabilities. He concluded by emphasizing that supporting specialised analysis and institutional partnerships is essential to reaching the targets of Saudi Imaginative and prescient 2030, constructing an inclusive society the place each particular person is empowered to thrive.
KFSHRC has been ranked first within the Center East and North Africa and fifteenth globally within the checklist of the world’s high 250 Educational Medical Facilities for the second consecutive yr and has been acknowledged as essentially the most precious healthcare model within the Kingdom and the Center East, based on the 2024 Model Finance rankings. It was included on this planet’s finest 250 hospitals and within the World’s Greatest Sensible Hospitals checklist for 2025 by Newsweek journal.
Elevate your perspective with NextTech Information, the place innovation meets perception.
Uncover the most recent breakthroughs, get unique updates, and join with a world community of future-focused thinkers.
Unlock tomorrow’s traits as we speak: learn extra, subscribe to our e-newsletter, and change into a part of the NextTech neighborhood at NextTech-news.com
